期刊文献+

血清降钙素原和C-反应蛋白水平对危重症患儿预后的意义 被引量:15

Significances of serum procalcitonin and C-reactive protein levels on prognosis of critically ill children
原文传递
导出
摘要 目的:分别对儿童危重症患者血清降钙素原和C-反应蛋白水平与预后的关系进行研究,探讨两者与危重症患者预后的关系。方法:回顾性分析2011年1月~2013年6月入住哈尔滨医科大学附属第一医院新生儿重症监护病房与儿科重症监护病房的108例患者,依据其入院时血清降钙素原和C-反应蛋白水平的测定值分别进行分组,计算病死率,并且进行统计学比较。血清降钙素原水平以0.5μg/L、2.0μg/L和10.0μg/L为界分为4组。血清C-反应蛋白水平以10mg/L与50mg/L为界分为3组。结果:患儿的病死率随血清降钙素原水平升高而增高(P〈0.05);而在C-反应蛋白的分析中,高水平的C-反应蛋白患儿与正常C-反应蛋白患儿相比,病死率无统计学差异(P〉0.05)。结论:儿童危重症患儿血清降钙素原水平与患儿预后关系密切。 Objective: To explore the relationship between serum procalcitonin, C -reactive protein levels and prognosis of critically ill children. Methods: A total of 108 critically ill children trom neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) in the hospital from January 2011 to June 2013 were analyzed retrospectively, and then they were divided into different groups according to the detection results of serum procalcitonin and C - reactive protein on admission, the mortality rates were calculated and compared statistically; the children were divided into four groups with different serum procalcitonin levels as demarcation points: 0. 5 μg/L, 2. 0 μg/L, and 10. 0 μg/L; the same children were divided into three groups with different serum C -reactive protein levels as demarcation points: 10 mg/L and 50 mg/L. Results: The mortality rate of children increased with increase of serum procalcitonin level (P 〈 0. 05 ) ; there was no statistically significant difference in mortality rate between children with high C - reactive protein level and children with normal C - reactive protein level ( P 〉 0. 05 ) . Conclusion : Serum procalcitonin level of critically ill children is closely correlated with prognosis of the children.
出处 《中国妇幼保健》 CAS 北大核心 2014年第6期880-882,共3页 Maternal and Child Health Care of China
基金 黑龙江省自然科学基金〔D2007-43〕
关键词 降钙素原 C-反应蛋白 危重病症 预后 Procalcitonin C -reactive protein Critically ill child Prognosis
  • 相关文献

参考文献7

二级参考文献21

  • 1钟冬梅.C反应蛋白的新应用[J].中国实用医药,2007,2(7):58-60. 被引量:5
  • 2Becker KL,Nylen ES,White JC,et al.Procalcitonin and the calcitonin gene family of peptides in inflammation,infection,and sepsis:a journey from calcitonin back to its precursors[J].J Clin Endocrinol Metab,2004,89(4):1512-1525.
  • 3Athhan F,Akagunduz B,Genel F,et al.Procalcitonin:a marker of neonatal sepsis[J].J Trop Pediatr,2002,48(1):10-14.
  • 4Dandona P,Nix D,Wilson MF,et al.Procalcitonin increase[J].J Clin Endocrinol Metab,1994,79(6):1605-1608.
  • 5Gendrel D,Bohunon C.Procalcitonin in pediatrics for differentiation of bacterial and viral infections[J].Intensive Care Med,2000,26(Suppl 2):S178-181.
  • 6Fazakas J,Gondos T,Varga M.Analysis of systemic and regionalprocalcitonin serum levels during liver transplantation[J].Transpl Int,2003,16(7):465-470.
  • 7刘志晶 张亚京 王鑫等.不同致病原所致小儿重症肺炎血清降钙素原的测定及 C-反应蛋白,白细胞计数的改变及其临床意义.中国优生优育,2009,15(1):19-21.
  • 8褚福堂,实用儿科学[M].第7版.北京:人民卫生出版社,2008:1167-1170.
  • 9Fartoukh M, Maitre B, lrlonore S, et al. Diagnosing pneumo- nia duringmechanical ventilati on:the clinical pul m0nary nfeeti on score revisited[J]. Am J Respir Crit Care Med, 2003,168 (2) :173-179.
  • 10Ramirez P, Garcia MA, Ferrer M, et al. Sequential measure- ments ofprocalcit onin levels in diagnosing ventilator-associat- ed pneumonia[J]. Eur Respir, 2008,31(2) : 356-362.

共引文献189

同被引文献111

  • 1杨勇,王宏志.应用血清降钙素原检测法诊断ICU病房感染的临床价值分析[J].求医问药(下半月),2013(1):99-100. 被引量:7
  • 2杨吉华,魏祥松,廖兵.血清降钙素原、超敏C反应蛋白和白细胞介素6鉴别新生儿感染性肺炎的意义[J].重庆医学,2007,36(12):1194-1195. 被引量:40
  • 3Huang,C T,Lee,L.N,Ho,C,et al.High serum levels of procalcitonin and soluble TREM-1 correlated with poor prog- nosis in pulmonary tuberculosis[J].Journal of Infection,2014,68(5):440.
  • 4Schrag,B,Iglesias,K,Mangin,P,et al.Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagno- sis of sepsis[J].International journal of legal medicine,2012,126(4):567.
  • 5Takashi Ogasawara,Hiroki Umezawa,Shinpei Kato,et al.Intrathoracic Administration of OK-432 Elevates the Serum Procalcitonin Levels[J].Internal medicine,2013,51(19):2727.
  • 6Bhandari KH,Newa M,Chapman J,et al.Synthesis,characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats[J].J Control Release,2012,158(1):44-52.
  • 7Chen WH,Zeng R,Lo WC,et al.The role of the ERK1/2pathway as an alternative to the aging-diminished cyclic AMP pathway in calcitonin-mediated chondrogenesis in human nucleus pulposus[J].Biomaterials,2012,33(33):8256-8264.
  • 8Ryan SM,Mc Morrow J,Umerska A,et al.An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis[J].J Control Release,2013,167(2):120-129.
  • 9Kauther MD,Neuerburg C,Wefelnberg F,et al.RANKLassociated suppression of particle-induced osteolysis in an aged model of Calcitonin andα-CGRP deficiency[J].Biomaterials,2013,34(12):2911-2919.
  • 10郑梅,赵青.降钙素原和C反应蛋白在婴儿重症肺炎呼衰和心衰中的变化[J].中国妇幼保健,2008,23(20):2858-2859. 被引量:7

引证文献15

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部